Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 1
2005 1
2006 3
2008 2
2009 1
2010 1
2011 11
2012 5
2013 9
2014 3
2015 5
2016 9
2017 9
2018 7
2019 8
2020 5
2021 5
2022 12
2023 14
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
Systematic Analysis of Homologous Recombination Deficiency Testing in Ovarian Cancer-Development of Recommendations for Optimal Assay Performance.
Romey M, Rodepeter F, Hattesohl A, Kaiser K, Teply-Szymanski J, Heitz F, Staebler A, Serra V, Grass A, Marmé F, Timms KM, Harter P, Llop-Guevara A, Kommoss S, Boekhoff J, Denkert C. Romey M, et al. Among authors: staebler a. Mod Pathol. 2024 Apr;37(4):100445. doi: 10.1016/j.modpat.2024.100445. Epub 2024 Feb 8. Mod Pathol. 2024. PMID: 38341130
Optical Emission Spectroscopy for the Real-Time Identification of Malignant Breast Tissue.
Guergan S, Boeer B, Fugunt R, Helms G, Roehm C, Solomianik A, Neugebauer A, Nuessle D, Schuermann M, Brunecker K, Jurjut O, Boehme KA, Dammeier S, Enderle MD, Bettio S, Gonzalez-Menendez I, Staebler A, Brucker SY, Kraemer B, Wallwiener D, Fend F, Hahn M. Guergan S, et al. Among authors: staebler a. Diagnostics (Basel). 2024 Feb 4;14(3):338. doi: 10.3390/diagnostics14030338. Diagnostics (Basel). 2024. PMID: 38337854 Free PMC article.
Image-guided metabolomics and transcriptomics reveal tumour heterogeneity in luminal A and B human breast cancer beyond glucose tracer uptake.
Yang Q, Deng S, Preibsch H, Schade TC, Koch A, Berezhnoy G, Zizmare L, Fischer A, Gückel B, Staebler A, Hartkopf AD, Pichler BJ, la Fougère C, Hahn M, Bonzheim I, Nikolaou K, Trautwein C. Yang Q, et al. Among authors: staebler a. Clin Transl Med. 2024 Feb;14(2):e1550. doi: 10.1002/ctm2.1550. Clin Transl Med. 2024. PMID: 38332687 Free PMC article.
Tissue-preserving treatment with non-invasive physical plasma of cervical intraepithelial neoplasia-a prospective controlled clinical trial.
Weiss M, Arnholdt M, Hißnauer A, Fischer I, Schönfisch B, Andress J, Gerstner S, Dannehl D, Bösmüller H, Staebler A, Brucker SY, Henes M. Weiss M, et al. Among authors: staebler a. Front Med (Lausanne). 2023 Aug 15;10:1242732. doi: 10.3389/fmed.2023.1242732. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37654659 Free PMC article.
Tumor-Free Resection Margin Distance in the Surgical Treatment of Node-Negative Squamous Cell Cancer of the Vulva Has No Impact on Survival: Analysis of a Large Patient Cohort in a Tertiary Care Center.
Taran FA, Pasternak J, Staebler A, Rohner A, Neis F, Engler T, Oberlechner E, Schönfisch B, Juhasz-Böss I, Hartkopf AD, Brucker S, Walter CB. Taran FA, et al. Among authors: staebler a. Cancers (Basel). 2023 Aug 15;15(16):4110. doi: 10.3390/cancers15164110. Cancers (Basel). 2023. PMID: 37627138 Free PMC article.
Comparison of Biosimilar Trastuzumab ABP 980 with Reference Trastuzumab in Neoadjuvant Therapy for HER2-positive Breast Cancer - an Analysis of a Large University Breast Cancer Centre.
Matovina S, Engler T, Volmer LL, Müller H, Grischke EM, Staebler A, Hahn M, Brucker SY, Hartkopf AD. Matovina S, et al. Among authors: staebler a. Geburtshilfe Frauenheilkd. 2022 Dec 2;83(6):694-701. doi: 10.1055/a-1963-7511. eCollection 2023 Jun. Geburtshilfe Frauenheilkd. 2022. PMID: 37614685 Free PMC article.
Breast cancer patient-derived microtumors resemble tumor heterogeneity and enable protein-based stratification and functional validation of individualized drug treatment.
Anderle N, Schäfer-Ruoff F, Staebler A, Kersten N, Koch A, Önder C, Keller AL, Liebscher S, Hartkopf A, Hahn M, Templin M, Brucker SY, Schenke-Layland K, Schmees C. Anderle N, et al. Among authors: staebler a. J Exp Clin Cancer Res. 2023 Aug 18;42(1):210. doi: 10.1186/s13046-023-02782-2. J Exp Clin Cancer Res. 2023. PMID: 37596623 Free PMC article.
103 results